EP3425068B1 - Agent de déchaulage exempt d'ammonium et d'acide borique, ses utilisations, processus de détartrage - Google Patents
Agent de déchaulage exempt d'ammonium et d'acide borique, ses utilisations, processus de détartrage Download PDFInfo
- Publication number
- EP3425068B1 EP3425068B1 EP18181640.6A EP18181640A EP3425068B1 EP 3425068 B1 EP3425068 B1 EP 3425068B1 EP 18181640 A EP18181640 A EP 18181640A EP 3425068 B1 EP3425068 B1 EP 3425068B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- deliming
- acid
- amino acid
- ammonium
- deliming agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003795 chemical substances by application Substances 0.000 title claims description 89
- 238000000034 method Methods 0.000 title claims description 38
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 title claims description 25
- 239000004327 boric acid Substances 0.000 title claims description 25
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 title claims description 23
- 229940024606 amino acid Drugs 0.000 claims description 126
- 235000001014 amino acid Nutrition 0.000 claims description 126
- 150000001413 amino acids Chemical class 0.000 claims description 84
- 150000007524 organic acids Chemical class 0.000 claims description 54
- -1 amino acid salt Chemical class 0.000 claims description 45
- 239000000654 additive Substances 0.000 claims description 35
- 239000000413 hydrolysate Substances 0.000 claims description 25
- 230000000996 additive effect Effects 0.000 claims description 24
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 19
- 102000008186 Collagen Human genes 0.000 claims description 18
- 108010035532 Collagen Proteins 0.000 claims description 18
- 229920001436 collagen Polymers 0.000 claims description 18
- 102000011782 Keratins Human genes 0.000 claims description 15
- 108010076876 Keratins Proteins 0.000 claims description 15
- 108010009736 Protein Hydrolysates Proteins 0.000 claims description 15
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 claims description 14
- 229940001584 sodium metabisulfite Drugs 0.000 claims description 14
- 235000010262 sodium metabisulphite Nutrition 0.000 claims description 14
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 12
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 claims description 12
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 12
- 239000004471 Glycine Substances 0.000 claims description 11
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 11
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 11
- 239000004472 Lysine Substances 0.000 claims description 11
- 229960002449 glycine Drugs 0.000 claims description 11
- 235000018977 lysine Nutrition 0.000 claims description 11
- 229960003646 lysine Drugs 0.000 claims description 11
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 10
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 9
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 9
- 229960003136 leucine Drugs 0.000 claims description 9
- 235000005772 leucine Nutrition 0.000 claims description 9
- 239000003531 protein hydrolysate Substances 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims description 6
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 claims description 6
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 6
- 239000001361 adipic acid Substances 0.000 claims description 6
- 235000011037 adipic acid Nutrition 0.000 claims description 6
- 239000001569 carbon dioxide Substances 0.000 claims description 6
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 6
- 235000004400 serine Nutrition 0.000 claims description 6
- 229960001153 serine Drugs 0.000 claims description 6
- 239000004475 Arginine Substances 0.000 claims description 5
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 claims description 5
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 5
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims description 5
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims description 5
- 235000009697 arginine Nutrition 0.000 claims description 5
- 229960003121 arginine Drugs 0.000 claims description 5
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 5
- 235000009582 asparagine Nutrition 0.000 claims description 5
- 229960001230 asparagine Drugs 0.000 claims description 5
- 235000004554 glutamine Nutrition 0.000 claims description 5
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims description 5
- 229960002743 glutamine Drugs 0.000 claims description 5
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 claims description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 4
- 239000004280 Sodium formate Substances 0.000 claims description 4
- 229910052783 alkali metal Inorganic materials 0.000 claims description 4
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 claims description 4
- 235000015165 citric acid Nutrition 0.000 claims description 4
- 229960005188 collagen Drugs 0.000 claims description 4
- 229910052700 potassium Inorganic materials 0.000 claims description 4
- 239000011591 potassium Substances 0.000 claims description 4
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 claims description 4
- HLBBKKJFGFRGMU-UHFFFAOYSA-M sodium formate Chemical compound [Na+].[O-]C=O HLBBKKJFGFRGMU-UHFFFAOYSA-M 0.000 claims description 4
- 235000019254 sodium formate Nutrition 0.000 claims description 4
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 claims description 3
- 150000001370 alpha-amino acid derivatives Chemical class 0.000 claims description 3
- 235000008206 alpha-amino acids Nutrition 0.000 claims description 3
- 239000000174 gluconic acid Substances 0.000 claims description 3
- 235000012208 gluconic acid Nutrition 0.000 claims description 3
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 claims description 3
- 239000004310 lactic acid Substances 0.000 claims description 3
- 235000014655 lactic acid Nutrition 0.000 claims description 3
- WBHQBSYUUJJSRZ-UHFFFAOYSA-M sodium bisulfate Chemical compound [Na+].OS([O-])(=O)=O WBHQBSYUUJJSRZ-UHFFFAOYSA-M 0.000 claims description 3
- 239000001384 succinic acid Substances 0.000 claims description 3
- FDKWRPBBCBCIGA-REOHCLBHSA-N (2r)-2-azaniumyl-3-$l^{1}-selanylpropanoate Chemical compound [Se]C[C@H](N)C(O)=O FDKWRPBBCBCIGA-REOHCLBHSA-N 0.000 claims description 2
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 claims description 2
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 claims description 2
- FDKWRPBBCBCIGA-UWTATZPHSA-N D-Selenocysteine Natural products [Se]C[C@@H](N)C(O)=O FDKWRPBBCBCIGA-UWTATZPHSA-N 0.000 claims description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims description 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims description 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 2
- 229910021380 Manganese Chloride Inorganic materials 0.000 claims description 2
- GLFNIEUTAYBVOC-UHFFFAOYSA-L Manganese chloride Chemical compound Cl[Mn]Cl GLFNIEUTAYBVOC-UHFFFAOYSA-L 0.000 claims description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims description 2
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 claims description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims description 2
- 239000004473 Threonine Substances 0.000 claims description 2
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 2
- 235000004279 alanine Nutrition 0.000 claims description 2
- 229960003767 alanine Drugs 0.000 claims description 2
- 150000001340 alkali metals Chemical class 0.000 claims description 2
- 150000003868 ammonium compounds Chemical class 0.000 claims description 2
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 claims description 2
- 235000003704 aspartic acid Nutrition 0.000 claims description 2
- 229960005261 aspartic acid Drugs 0.000 claims description 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims description 2
- 235000018417 cysteine Nutrition 0.000 claims description 2
- 229960002433 cysteine Drugs 0.000 claims description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims description 2
- BHDAXLOEFWJKTL-UHFFFAOYSA-L dipotassium;carboxylatooxy carbonate Chemical compound [K+].[K+].[O-]C(=O)OOC([O-])=O BHDAXLOEFWJKTL-UHFFFAOYSA-L 0.000 claims description 2
- VTIIJXUACCWYHX-UHFFFAOYSA-L disodium;carboxylatooxy carbonate Chemical compound [Na+].[Na+].[O-]C(=O)OOC([O-])=O VTIIJXUACCWYHX-UHFFFAOYSA-L 0.000 claims description 2
- 235000013922 glutamic acid Nutrition 0.000 claims description 2
- 229960002989 glutamic acid Drugs 0.000 claims description 2
- 239000004220 glutamic acid Substances 0.000 claims description 2
- 235000014304 histidine Nutrition 0.000 claims description 2
- 229960002885 histidine Drugs 0.000 claims description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 2
- 229960000310 isoleucine Drugs 0.000 claims description 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 2
- 229940071125 manganese acetate Drugs 0.000 claims description 2
- 239000011565 manganese chloride Substances 0.000 claims description 2
- 235000002867 manganese chloride Nutrition 0.000 claims description 2
- 229940099607 manganese chloride Drugs 0.000 claims description 2
- 229940099596 manganese sulfate Drugs 0.000 claims description 2
- 239000011702 manganese sulphate Substances 0.000 claims description 2
- 235000007079 manganese sulphate Nutrition 0.000 claims description 2
- UOGMEBQRZBEZQT-UHFFFAOYSA-L manganese(2+);diacetate Chemical compound [Mn+2].CC([O-])=O.CC([O-])=O UOGMEBQRZBEZQT-UHFFFAOYSA-L 0.000 claims description 2
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 claims description 2
- 235000006109 methionine Nutrition 0.000 claims description 2
- 229930182817 methionine Natural products 0.000 claims description 2
- 229960004452 methionine Drugs 0.000 claims description 2
- 229960005190 phenylalanine Drugs 0.000 claims description 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims description 2
- 235000011056 potassium acetate Nutrition 0.000 claims description 2
- WFIZEGIEIOHZCP-UHFFFAOYSA-M potassium formate Chemical compound [K+].[O-]C=O WFIZEGIEIOHZCP-UHFFFAOYSA-M 0.000 claims description 2
- RWPGFSMJFRPDDP-UHFFFAOYSA-L potassium metabisulfite Chemical compound [K+].[K+].[O-]S(=O)S([O-])(=O)=O RWPGFSMJFRPDDP-UHFFFAOYSA-L 0.000 claims description 2
- 229940043349 potassium metabisulfite Drugs 0.000 claims description 2
- 235000010263 potassium metabisulphite Nutrition 0.000 claims description 2
- OTYBMLCTZGSZBG-UHFFFAOYSA-L potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 claims description 2
- 229910052939 potassium sulfate Inorganic materials 0.000 claims description 2
- 235000011151 potassium sulphates Nutrition 0.000 claims description 2
- 235000013930 proline Nutrition 0.000 claims description 2
- 229960002429 proline Drugs 0.000 claims description 2
- 235000016491 selenocysteine Nutrition 0.000 claims description 2
- 229940055619 selenocysteine Drugs 0.000 claims description 2
- ZKZBPNGNEQAJSX-UHFFFAOYSA-N selenocysteine Natural products [SeH]CC(N)C(O)=O ZKZBPNGNEQAJSX-UHFFFAOYSA-N 0.000 claims description 2
- 239000011734 sodium Substances 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- 239000001632 sodium acetate Substances 0.000 claims description 2
- 235000017281 sodium acetate Nutrition 0.000 claims description 2
- 229940079827 sodium hydrogen sulfite Drugs 0.000 claims description 2
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 claims description 2
- 229940045872 sodium percarbonate Drugs 0.000 claims description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 claims description 2
- 235000011152 sodium sulphate Nutrition 0.000 claims description 2
- 235000008521 threonine Nutrition 0.000 claims description 2
- 229960002898 threonine Drugs 0.000 claims description 2
- 229960004799 tryptophan Drugs 0.000 claims description 2
- 235000002374 tyrosine Nutrition 0.000 claims description 2
- 229960004441 tyrosine Drugs 0.000 claims description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 2
- 229960004295 valine Drugs 0.000 claims description 2
- 239000004474 valine Substances 0.000 claims description 2
- 238000005406 washing Methods 0.000 claims description 2
- KJFMBFZCATUALV-UHFFFAOYSA-N phenolphthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2C(=O)O1 KJFMBFZCATUALV-UHFFFAOYSA-N 0.000 description 28
- 238000007796 conventional method Methods 0.000 description 21
- 239000000203 mixture Substances 0.000 description 19
- 239000010985 leather Substances 0.000 description 18
- 206010039509 Scab Diseases 0.000 description 17
- 150000003863 ammonium salts Chemical class 0.000 description 16
- 241000283690 Bos taurus Species 0.000 description 14
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 13
- 238000006386 neutralization reaction Methods 0.000 description 13
- 238000005554 pickling Methods 0.000 description 13
- 230000003139 buffering effect Effects 0.000 description 11
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 10
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 9
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 9
- 235000011941 Tilia x europaea Nutrition 0.000 description 9
- 239000004571 lime Substances 0.000 description 9
- 238000004519 manufacturing process Methods 0.000 description 8
- 239000002253 acid Substances 0.000 description 7
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 6
- 239000000920 calcium hydroxide Substances 0.000 description 6
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 6
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 5
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 235000005985 organic acids Nutrition 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- 229910021529 ammonia Inorganic materials 0.000 description 4
- 235000019270 ammonium chloride Nutrition 0.000 description 4
- 235000011130 ammonium sulphate Nutrition 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 3
- 235000011116 calcium hydroxide Nutrition 0.000 description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
- 230000035515 penetration Effects 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 102000035195 Peptidases Human genes 0.000 description 2
- 239000004642 Polyimide Substances 0.000 description 2
- 150000001412 amines Chemical group 0.000 description 2
- 229910001424 calcium ion Inorganic materials 0.000 description 2
- 159000000007 calcium salts Chemical class 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 2
- 229910000069 nitrogen hydride Inorganic materials 0.000 description 2
- 229920001721 polyimide Polymers 0.000 description 2
- 238000002203 pretreatment Methods 0.000 description 2
- 231100000615 substance of very high concern Toxicity 0.000 description 2
- WXHLLJAMBQLULT-UHFFFAOYSA-N 2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-n-(2-methyl-6-sulfanylphenyl)-1,3-thiazole-5-carboxamide;hydrate Chemical compound O.C=1C(N2CCN(CCO)CC2)=NC(C)=NC=1NC(S1)=NC=C1C(=O)NC1=C(C)C=CC=C1S WXHLLJAMBQLULT-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 241000282994 Cervidae Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 108010019160 Pancreatin Proteins 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 206010074268 Reproductive toxicity Diseases 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- XKMRRTOUMJRJIA-UHFFFAOYSA-N ammonia nh3 Chemical compound N.N XKMRRTOUMJRJIA-UHFFFAOYSA-N 0.000 description 1
- 229910052925 anhydrite Inorganic materials 0.000 description 1
- 238000013475 authorization Methods 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 229940055695 pancreatin Drugs 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 230000007696 reproductive toxicity Effects 0.000 description 1
- 231100000372 reproductive toxicity Toxicity 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 229910000342 sodium bisulfate Inorganic materials 0.000 description 1
- 239000002425 soil liming agent Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000004065 wastewater treatment Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C14—SKINS; HIDES; PELTS; LEATHER
- C14C—CHEMICAL TREATMENT OF HIDES, SKINS OR LEATHER, e.g. TANNING, IMPREGNATING, FINISHING; APPARATUS THEREFOR; COMPOSITIONS FOR TANNING
- C14C1/00—Chemical treatment prior to tanning
- C14C1/08—Deliming; Bating; Pickling; Degreasing
Definitions
- the present invention relates to ammonium and boric acid free deliming agent, and to a leather deliming process by using the said deliming agent.
- pretreatments for raw pelts should be done before tanning and crusting.
- Liming is one of the pretreatments to remove hair and unwanted proteins usually by soaking the pelts in a lime bath. Then it is necessary to delime the pelts so as to bring them into a proper state of alkalinity. Deliming is about removing calcium hydroxide from pelts including surfaces and inner parts thereof and lowering pelts pH value until around 8. During the deliming, if pH value of the pelts decreases too fast, excessive deliming happens and leads to surface acid swelling. To prevent grain damage and acid swelling, mild deliming should be carried out by applying satisfactory deliming agents which have good buffering capacity and sufficient in lime removal.
- ammonium salts such as ammonium sulfate, ammonium chloride, etc.
- US 2,318,454 which was granted May 4, 1943 used ammonium salt as deliming component.
- Ammonium salts have been widely accepted in leather industry due to the following characteristics: i) cheap raw material prices compared with organic compounds; ii) buffering effect, which provides a narrow pH range in deliming float and prevents the surface damage of the pelts and a mild removal of lime from the limed pelt.
- Ammonium salts are known as good buffering agents in deliming recipes, that generate leather with clean surface, even dying property and good handle feeling.
- ammonium salts When ammonium salts are used for deliming purpose, they react with calcium hydroxide which are physically and chemically bonded on the limed pelt. For instance, the reactions between ammonium sulfate or ammonium chloride and calcium hydroxide are illustrated below: Ca(OH) 2 +NH 4 Cl ⁇ CaCl 2 +NH 3 +H 2 O Ca(OH) 2 +(NH 4 ) 2 SO 4 ⁇ CaSO 4 +NH 3 +H 2 O
- Ammonium based deliming agents have two shortcomings, which limit their application in industry.
- the disadvantages are: i) the ammonia released during deliming leads to the workers' exposure in unsafe environment; ii) the high NH 3 -N content in tannery effluent made it necessary to perform NH 3 -N removal, which increases the cost and duration in wastewater treatment.
- inorganic acid like boric acid
- small molecular organic acids including lactic acid, citric acid, succinic acid, or adipic acid
- macromolecule such as polyimides, polysuccinimide and hydroxy polysuccinimide.
- Boric acid has very good buffering effect in deliming float and was used as the alternative deliming agent, which enables even deliming across the thick pelts and generates leather with good quality.
- boric acid has reproductive toxicity and is listed in SVHC (substance of very high concern) according to REACH (Registration, evaluation, authorization and restriction of chemicals).
- SVHC substance of very high concern
- REACH Registration, evaluation, authorization and restriction of chemicals
- CN 102010917A mentions an ammonia free deliming agent, which is the combination of two organic acids.
- One organic acid is a small molecular organic acid, such as citric acid, or succinic acid; the other organic acid is gluconic acid or sulfosalicylic acid.
- the above used small molecular organic acids have very limited buffering effect in liming float.
- WO 2013/107233 also discloses an ammonia free deliming agent.
- the deliming agent comprises polysuccinimide or hydroxy polysuccinimide.
- Polyimides, polysuccinimides are polymers, which are slow in penetrating into thick limed pelts.
- DE2113214A1 describes the treatment of limed pelts with proteolytic enzymes using in a first step aqueous solutions of amino acids or their salts and in a second step a proteolytic enzyme mixture of papain and pancreatin at 20°C to 50°C until the desired bating level is achieved.
- the deliming step comprises also traditional deliming agents such as ammonium sulfate, sodium bisulfate or ammonium chloride besides aqueous amino acids or aqueous amino acid salts.
- the deliming agent comprises amino acid component.
- the deliming agent has high lime dissolving value and good buffering capacity during deliming process, and ensures zero add-on NH 3 -N load originating from liming agents, resulting in low NH 3 -N load in deliming effluent.
- the final NH 3 -N value in effluent is around 100 ppm.
- the protonated amine groups After reacting with hydroxide ion, the protonated amine groups generate amine compounds, which are weak bases and provide buffering capacity for the system. Good buffering capacity allows the pH value to decline gradually and to prevent acid swelling on the grain layer.
- the carboxylic groups After reacting with calcium ion, the carboxylic groups form soluble calcium salts, enabling the effective removal of lime and produce wet blue/wet white with clean surface.
- Amino acids in the present invention can be individually used in the deliming agent or combined with some additives, and achieve good deliming effect with no help of ammonium salts, thus enabling the replacement of conventionally used boric acid and ammonium salts.
- the invention also discloses a deliming process.
- the present deliming agent has the following features: i) amino acids are utilized as deliming agent, which are safe compounds both to environment and workers; ii) amino acids will not introduce NH 3 -N burden into deliming effluent, therefore the reduction of NH 3 -N generated in deliming process can be achieved.
- the present deliming agent Compared with the known ammonium free deliming agents, the present deliming agent has good deliming effect which is almost equal to ammonium salts and will not cause acid swelling.
- the object of the present invention is therefore to provide an ammonium and boric acid free deliming agent, which comprises amino acid component and no ammonium compound; the amino acid component comprises amino acid, amino acid salt, and/or protein hydrolysate which contains amino acid and/or amino acid salt.
- the amino acid component could mean any component so long as it comprises amino acid and/or amino acid ion and could react with Ca(OH) 2 without bringing any negative effect to deliming.
- the amino acid component in the present invention could comprise amino acid, amino acid salt, and/or protein hydrolysate which contains amino acid and amino acid salt.
- the amino acid in the present invention is the commonly known amino acid which contains amine and carboxyl functional group, along with a side-chain (R group) specific to each amino acid.
- Amino acid having good buffering capacity and lime dissolving ability is preferably used in the present invention.
- the amino acid is ⁇ -amino acid, which has both the amine and the carboxyl functional group attached to the ⁇ -carbon atom.
- the generic formula of the ⁇ -amino acid is H 2 NCH(R)COOH in most cases.
- the amino acid comprises at least one selected from the group consisting of glycine, alanine, valine, leucine, isoleucine, phenylalanine, tryptophan, tyrosine, histidine, serine, threonine, cysteine, aspartic acid, glutamic acid, asparagine, glutamine, lysine, arginine, proline, methionine and selenocysteine. Based on amounts of experiments, it was found that glycine, serine, asparagine, leucine, glutamine and/or lysine are more preferably.
- the amino acid in the present invention can be natural or synthetized amino acid. All the stereoisomers of amino acid can be used in the present invention, such as D-, L-, or D,L- amino acid.
- the amino acid salt in the present invention is preferably water soluble amino acid salt.
- the common amino acid salt which will not precipitate with calcium ion could be used in the present invention.
- the amino acid salt preferably comprises alkali metal salt and/or hydrochloride salt.
- the alkali metal is preferably sodium and/or potassium.
- the protein hydrolysate is a mixture of amino acids and/or amino acid salts, which could be prepared according to the conventional method, for example by splitting proteins with acid, alkali, and/or enzyme. All proteins that could be hydrolyzed into amino acid and/or amino acid salt can be used in the present invention.
- the protein hydrolysate comprises collagen hydrolysate and/or keratin hydrolysate.
- the degree of hydrolysis is not limited in the present invention, so long as there is amino acid in the protein hydrolysate.
- the hydrolyzation into high content of amino acids level is preferred.
- the deliming agent in the present invention could further comprise organic acid and/or carbon dioxide, the organic acid herein excluding amino acid.
- the organic acids for use in the present invention are those that are commonly used in leather manufacturing processes.
- the organic acid comprises at least one selected from the group consisting of lactic acid, citric acid, adipic acid, malonic acid, succinic acid, glutaric acid, and gluconic acid; more preferably succinic acid and adipic acid.
- the combination of the amino acid component and the organic acid could realize better deliming efficiency.
- the deliming agent in the present invention could further comprise additives.
- the additives which come into consideration in the present invention are the conventional additives in leather manufacturing industry.
- the preferable additive is oxidizing agent and/or catalyst.
- the preferable additive comprises at least one selected from the group consisting of manganese sulfate, manganese chloride, manganese acetate, sodium formate, potassium formate, sodium hydrogen sulfite, sodium metabisulfite, potassium metabisulfite, sodium acetate, potassium acetate, sodium sulfate, potassium sulfate, sodium hydrosulfate, potassium hydrosulfate, sodium percarbonate and potassium percarbonate.
- the content of the amino acid component in the deliming agent is calculated according to the content of the total amino acids and amino acid salts in the deliming agent.
- the amino acid and amino acid salt in the protein hydrolysate is used to calculate the content of the total amino acids and the amino acid salts.
- the content of the total amino acids and the amino acid salts in the deliming agent could be chosen according to the conventional methods in leather process industry.
- the content of the total amino acids and the amino acid salts in the deliming agent is 40-100 wt%, more preferably 55-100 wt%, further more preferably 70-100 wt%, most preferably 80-100 wt%, wt% is based on the total weight of the total amino acids, the amino acid salts, the organic acid and the additives.
- the content of the organic acid in the deliming agent could be chosen according to conventional methods in leather process industry, preferably is 25 wt% or less; more preferably 5-20 wt%; most preferably 5-10 wt%, wt% is based on the total weight of the total amino acids, the amino acid salts, the organic acid and the additives.
- the content of the additives in the deliming agent could be chosen according to conventional method in leather process industry, preferably is 25 wt% or less, more preferably 20 wt% or less, most preferably 10 wt% or less, wt% is based on the total weight of the total amino acids, the amino acid salts, the organic acid and the additive.
- the deliming agent comprises the amino acid component in which the content of the total amino acids and the amino acid salts is 55-100 wt%, 0-20 wt% of the organic acid and 0-25 wt% of the additive, wt% is all based on the total weight of the total amino acids, the amino acid salts, the organic acid and the additives; and the amino acid component is glycine, asparagine, glutamine, lysine, leucine, serine, collagen hydrolysate and/or keratin hydrolysate.
- the deliming agent comprises the amino acid component in which the content of the total amino acids and the amino acid salts is 80-100 wt%, 0-10 wt% of the organic acid and 0-10 wt% of the additives, wt% is all based on the total weight of the total amino acids, the amino acid salts, the organic acid and the additive; the amino acid component is glycine, lysine, serine, leucine, collagen hydrolysate and/or keratin hydrolysate.
- Another object of the present invention is to provide a deliming process, comprising deliming step: deliming limed pelt with the deliming agent of the present invention.
- the pelt in the present invention could be also referred to as hide in the leather manufacturing field.
- the pelt could come from common mammals used in the leather manufacturing field, such as cattle, sheep, pig, deer, or from common birds.
- the deliming process comprises: (A) a pre-deliming step: pre-deliming the limed pelt with the additive, the organic acid and/or the carbon dioxide; and (B) the deliming step: deliming the limed pelt with the deliming agent.
- the step (A) preferably comprises (i) washing the limed pelt with water, removing the float; (ii) pre-deliming the limed pelt with the additive, and the organic acid and/or carbon dioxide; and (iii) when the pH value of float is about 8, draining the float.
- the deliming step (B) shall be conducted as deliming the limed pelt in an aqueous solution of the deliming agent.
- the additive in step (A) is the same additive mentioned above in the deliming agent.
- the organic acid in step (A) is the same organic acid mentioned above in the deliming agent.
- the amount of the additive could be chosen according to conventional methods in the leather manufacturing process, preferably is 0.05-0.3 wt% of the limed pelt.
- the amount of the organic acid could be chosen according to conventional methods in the leather manufacturing process, preferably is 0.1-0.5 wt% of the limed pelt.
- the amount of the water in step (i) or in the aqueous solution of the deliming agent could be chosen according to conventional methods in leather manufacturing process, preferably is 300 wt% of the limed pelt or less, more preferably 200 wt% of the limed pelt or less, based on the total weight of the limed pelt.
- the step (B) preferably comprises: (iv) deliming the limed pelt with the deliming agent; and (v) ending the deliming step.
- the amount of the deliming agent is calculated based on the amount of the total amino acids and the amino acid salts in the deliming agent.
- the amount of the total amino acids and the amino acid salts in the deliming agent is preferably 1-10 wt% of the limed pelt, more preferably 1-5 wt% of the limed pelt, most preferably 1-2.5 wt% of the limed pelt.
- the deliming process in the present invention could be conducted in the conventional temperature range, preferred is 5°C-35°C, more preferred is 25°C-35°C.
- the end of the deliming step could be decided according to conventional methods in leather process industry.
- the deliming step could be ended.
- the time of the deliming step is preferably from 1 to 6 hours, more preferably from 1 to 3 hours.
- the "about 8" in the invention refers to 8 ⁇ 0.8.
- pH value of the float is preferably monitored.
- the limed pelt could be limed according to conventional liming methods in leather process industry.
- the present invention has the following benefits: (1) raw material does not contain boric acid, and is compliant with safe operation; (2) without using ammonium salts and hence greatly reduces the ammonia-nitrogen values in the effluent; (3) no ammonia releasing during deliming process, which facilitates safe operation; (4) amino acids have good buffering capacity during deliming pH range, which enables the successful lime removal from the limed pelts without inducing acid swelling especially on the grain layer; (5) amino acids have high solubility in water and small molecules which enables fast penetration into limed pelts; (6) the formation of soluble calcium salts between amino acids compounds and lime resulting in high lime removal efficiency, which enables a clean pelt surface and soft handle feeling of the crust.
- the deliming process comprises the following steps:
- crust was obtained after bating, pickling, chrome tanning, retanning, neutralization, dying and fat-liquoring.
- the deliming process comprises the following steps:
- crust was obtained after bating, pickling, chrome tanning, retanning, neutralization, dying and fat-liquoring.
- the deliming process comprises the following steps:
- crust was obtained after bating, pickling, chrome tanning, retanning, neutralization, dying and fat-liquoring.
- the deliming process comprises the following steps:
- crust was obtained after bating, pickling, chrome tanning, retanning, neutralization, dying and fat-liquoring.
- the content of the amino acids in the collagen hydrolysate is 40 wt%.
- the deliming process comprises the following steps:
- crust was obtained after bating, pickling, chrome tanning, retanning, neutralization, dying and fat-liquoring.
- the content of the amino acids in the keratin hydrolysate is 43 wt%.
- the deliming process comprises the following steps:
- crust was obtained after bating, pickling, chrome tanning, retanning, neutralization, dying and fat-liquoring.
- the deliming process comprises the following steps:
- crust was obtained after bating, pickling, chrome tanning, retanning, neutralization, dying and fat-liquoring.
- the content of the amino acids in the collagen hydrolysate is 70 wt%.
- the deliming process comprises the following steps:
- crust was obtained after bating, pickling, chrome tanning, retanning, neutralization, dying and fat-liquoring.
- the content of the amino acids in the collagen hydrolysate is 70 wt%.
- the deliming process comprises the following steps:
- crust was obtained after bating, pickling, chrome tanning, retanning, neutralization, dying and fat-liquoring.
- the content of the amino acids in the keratin hydrolysate is 43 wt%.
- the deliming process comprises the following steps:
- crust was obtained after bating, pickling, chrome tanning, retanning, neutralization, dying and fat-liquoring.
- the content of the amino acids in the keratin hydrolysate is 28 wt%.
- the deliming process comprises the following steps:
- crust was obtained after bating, pickling, chrome tanning, retanning, neutralization, dying and fat-liquoring.
- the content of the amino acids in the collagen hydrolysate is 40 wt%.
- the deliming process comprises the following steps:
- crust was obtained after bating, pickling, chrome tanning, retanning, neutralization, dying and fat-liquoring.
- the deliming process comprises the following steps:
- deliming with ammonium salts glycine, lysine, leucine, arginine, collagen hydrolysate, keratin hydrolysate achieved the end pH value of around 8, which means that amino acids have similar buffering capacity with ammonium salts.
- the deliming effluent of amino acids has NH 3 -N value around 100 ppm, which is less than 5% of ammonium salts deliming effluent. Low NH 3 -N value can significantly reduce effluent treatment time and cost.
- the crusts obtained from all the examples have even color, soft handle feeling and very fine grain, which is comparable with comparative example 1.
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Treatment And Processing Of Natural Fur Or Leather (AREA)
Claims (21)
- Agent de déchaulage sans ammonium et sans acide borique, qui comprend un composant acide aminé et aucun composé ammonium ; le composant acide aminé comprenant un acide aminé, un sel d'acide aminé et/ou un hydrolysat de protéine qui contient un acide aminé et/ou un sel d'acide aminé.
- Agent de déchaulage sans ammonium et sans acide borique selon la revendication 1, dans lequel l'acide aminé est un acide aminé-a.
- Agent de déchaulage sans ammonium et sans acide borique selon la revendication 1 ou 2, dans lequel l'acide aminé comprend au moins un acide aminé choisi dans le groupe constitué par la glycine, l'alanine, la valine, la leucine, l'isoleucine, la phénylalanine, le tryptophane, la tyrosine, l'histidine, la sérine, thréonine, cystéine, acide aspartique, acide glutamique, asparagine, glutamine, lysine, arginine, proline, méthionine et sélénocystéine.
- Agent de déchaulage exempt d'ammonium et d'acide borique selon l'une quelconque des revendications précédentes, dans lequel le sel d'acide aminé comprend un sel de métal alcalin et/ou un sel de chlorhydrate.
- Agent de déchaulage sans ammonium et sans acide borique selon la revendication 4, dans lequel le métal alcalin est le sodium et/ou le potassium.
- Agent de déchaulage sans ammonium et sans acide borique selon l'une quelconque des revendications précédentes, dans lequel l'hydrolysat de protéines comprend un hydrolysat de collagène et/ou un hydrolysat de kératine.
- Agent de déchaulage sans ammonium et sans acide borique selon l'une quelconque des revendications précédentes, dans lequel l'agent de déchaulage comprend en outre de l'acide organique et/ou du dioxyde de carbone.
- Agent de déchaulage sans ammonium et sans acide borique selon la revendication 7, dans lequel l'acide organique comprend au moins un acide choisi dans le groupe constitué par l'acide lactique, l'acide citrique, l'acide adipique, l'acide malonique, l'acide succinique, l'acide glutarique et l'acide gluconique ; de préférence est l'acide succinique et l'acide adipique.
- Agent de déchaulage sans ammonium et sans acide borique selon l'une quelconque des revendications précédentes, dans lequel l'agent de déchaulage comprend en outre un additif.
- Agent de déchaulage sans ammonium et sans acide borique selon la revendication 9, dans lequel
l'additif comprend au moins un additif choisi dans le groupe consistant en sulfate de manganèse, chlorure de manganèse, acétate de manganèse, formiate de sodium, formiate de potassium, hydrogénosulfite de sodium, métabisulfite de sodium, métabisulfite de potassium, acétate de sodium, acétate de potassium, sulfate de sodium, sulfate de potassium, hydrosulfate de sodium, hydrosulfate de potassium, percarbonate de sodium et percarbonate de potassium. - Agent de déchaulage sans ammonium et sans acide borique selon l'une quelconque des revendications précédentes, dans lequel la teneur en composant d'acide aminé dans l'agent de déchaulage est calculée en fonction de la teneur en acides aminés et en sels d'acides aminés totaux dans l'agent de déchaulage, la teneur en acides aminés et en sels d'acides aminés totaux dans l'agent de déchaulage étant de 40 à 100% en poids, de préférence de 55 à 100% en poids, plus préférablement 70 à 100% en poids, le plus préférablement de 80 à 100% en poids, le % en poids étant basé sur le poids total des acides aminés et des sels d'acides aminés totaux, de l'acide organique et de l'additif.
- Agent de déchaulage sans ammonium et sans acide borique selon la revendication 7 ou 8, dans lequel la teneur en acide organique dans l'agent de déchaulage est de 25% en poids ou moins, de préférence de 5 à 20% en poids, plus préférablement de 5 à 10% en poids, le % en poids étant basé sur le poids total des acides aminés et des sels d'acides aminés totaux, de l'acide organique et de l'additif.
- Agent de déchaulage sans ammonium et sans acide borique selon les revendications 9 ou 10, dans lequel la teneur de l'additif dans l'agent de déchaulage est de 25% en poids ou moins, de préférence 20% en poids ou moins, plus préférablement 10% en poids ou moins, le % en poids étant basé sur le poids total des acides aminés et des sels d'acides aminés totaux, de l'acide organique et de l'additif.
- Agent de déchaulage sans ammonium et sans acide borique selon l'une quelconque des revendications précédentes, dans lequel l'agent de déchaulage comprend le composant acide aminé dans lequel la teneur en acides aminés et en sels d'acides aminés totaux est de 55 à 100% en poids, 0 -20% en poids de l'acide organique et 0-25% en poids de l'additif, le % en poids étant basé sur le poids total des acides aminés et des sels d'acides aminés totaux, de l'acide organique et de l'additif ; le composant acide aminé est la glycine, l'asparagine, la glutamine, la lysine, la leucine, la sérine, l'hydrolysat de collagène et/ou l'hydrolysat de kératine.
- Agent de déchaulage sans ammonium et sans acide borique selon la revendication 14, dans lequel l'agent de déchaulage comprend le composant acide aminé dans lequel la teneur en acides aminés et en sels d'acides aminés totaux est de 80 à 100% en poids, 0 à 10% en poids de l'acide organique et 0 à 10% en poids de l'additif, le % en poids étant basé sur le poids total des acides aminés et des sels d'acides aminés totaux, de l'acide organique et de l'additif.
- Procédé de déchaulage, comprenant l'étape de déchaulage consistant à déchauler la peau chaulée avec l'agent de déchaulage exempt d'ammonium et d'acide borique tel que défini dans l'une quelconque des revendications précédentes.
- Procédé de déchaulage selon la revendication 16, comprenant les étapes suivantes :(A) une étape de pré-déchaulage comprenant le pré-déchaulage de la peau chaulée avec l'additif, l'acide organique et/ou le dioxyde de carbone ; l'acide organique tel que défini dans la revendication 8, l'additif tel que défini dans la revendication 10 ; et(B) l'étape de déchaulage comprenant le déchaulage de la peau chaulée avec l'agent de déchaulage.
- Procédé de déchaulage selon la revendication 17, dans lequel l'étape (A) comprend (i) le lavage de la peau chaulée avec de l'eau, en enlevant le milieu d'application ; (ii) le pré-déchaulage de la peau chaulée avec l'additif et l'acide organique et/ou le dioxyde de carbone ; et (iii) lorsque la valeur de pH du milieu d'application est d'environ 8, le vidange du milieu d'application.
- Procédé de déchaulage selon la revendication 17 ou 18, dans lequel à l'étape (A), la quantité d'additif est de 0,05 à 0,3% en poids, de préférence de 0,1 à 0,5% en poids de la peau chaulée.
- Procédé de déchaulage selon au moins l'une des revendications 17 à 19, dans lequel l'étape (B) comprend : (iv) le déchaulage de la peau chaulée avec l'agent de déchaulage ; et (v) la terminaison de l'étape de déchaulage.
- Procédé de déchaulage selon au moins l'une des revendications 16 à 20, dans lequel la quantité d'agent de déchaulage est calculée sur la base de la quantité des acides aminés et des sels d'acides aminés totaux dans l'agent de déchaulage, la quantité des acides aminés et les sels d'acides aminés totaux dans l'agent de déchaulage étant de 1 à 10% en poids, de préférence de 1 à 5% en poids, plus préférablement de 1 à 2,5% en poids de la peau chaulée.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2017092105 | 2017-07-06 |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3425068A1 EP3425068A1 (fr) | 2019-01-09 |
EP3425068B1 true EP3425068B1 (fr) | 2021-08-04 |
Family
ID=62873216
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP18181640.6A Active EP3425068B1 (fr) | 2017-07-06 | 2018-07-04 | Agent de déchaulage exempt d'ammonium et d'acide borique, ses utilisations, processus de détartrage |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP3425068B1 (fr) |
CN (1) | CN109295264B (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109385494A (zh) * | 2018-12-03 | 2019-02-26 | 四川大学 | 一种无铵盐无硼酸的皮革脱灰剂 |
NL2027083B1 (en) | 2020-12-09 | 2022-07-07 | Stahl Int B V | Process for deliming of hides, skins or pelts |
EP4032989B1 (fr) | 2021-01-22 | 2023-10-11 | TFL Ledertechnik GmbH | Composition de déchaulage et procédé de déchaulage destiné au déchaulage des peaux |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR502225A (fr) * | 1919-08-05 | 1920-05-07 | Georges Lengrand | Procédé de déchaulage des peaux en mégisserie |
DE693065C (de) * | 1938-02-07 | 1940-07-01 | I G Farbenindustrie Akt Ges | Verfahren zum Entkaelken von geaescherten Haeuten und Fellen |
DE2113214A1 (de) * | 1971-03-18 | 1972-09-28 | Diamalt Ag | Verfahren zum Behandeln geaescherter Bloessen |
DE3108428A1 (de) * | 1981-03-06 | 1982-09-23 | Basf Ag, 6700 Ludwigshafen | Verfahren zum entkaelken von haeuten |
CN102010917A (zh) * | 2010-11-22 | 2011-04-13 | 陕西科技大学 | 一种无氨氮制革脱灰剂及其制备方法 |
EP2853605A1 (fr) * | 2013-09-30 | 2015-04-01 | Rhodia Poliamida E Especialidades Ltda | Procédé de tannage pour obtenir du cuir |
-
2018
- 2018-07-04 EP EP18181640.6A patent/EP3425068B1/fr active Active
- 2018-07-06 CN CN201810735871.6A patent/CN109295264B/zh active Active
Non-Patent Citations (1)
Title |
---|
None * |
Also Published As
Publication number | Publication date |
---|---|
CN109295264B (zh) | 2024-04-23 |
EP3425068A1 (fr) | 2019-01-09 |
CN109295264A (zh) | 2019-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3425068B1 (fr) | Agent de déchaulage exempt d'ammonium et d'acide borique, ses utilisations, processus de détartrage | |
EP3425069B1 (fr) | Procédé de déchaulage | |
AU2009231404B2 (en) | Process for pre-tanning and tanning skins with organic tanning agent | |
RU2520657C2 (ru) | Средство и способ дубления шкур и кож | |
CA1038315A (fr) | Traitement des peaux aux enzymes | |
JPH06502886A (ja) | 皮革の製造におけるホスホニウム化合物の使用 | |
EP3456848B1 (fr) | Agent de déchaulage et son utilisation et procédé de déchaulage | |
CN113913563B (zh) | 一种脱灰-软化-浸酸一体化清洁制革方法及其应用 | |
US20070143930A1 (en) | Method for removing horn substances from animal skin | |
AU763681B2 (en) | Tanning leather | |
CN109415774B (zh) | 生产皮革的方法 | |
JP4114046B2 (ja) | 酵素脱毛処理剤および酵素脱毛法 | |
US20080168606A1 (en) | Product For Pelt Conditioning For Tanning: Process For Pelt Conditioning and Following Tanning | |
US20220347069A1 (en) | Process for Dehairing and Liming of Hides, Skins or Pelts | |
SE448885B (sv) | Forfarande for vekning av hudar och skinn vid surt ph | |
WO2001042513A1 (fr) | Agent d'ebourrage enzymatique a utiliser dans le tannage pour la production de cuir et procede de traitement par ebourrage enzymatique | |
NL2027083B1 (en) | Process for deliming of hides, skins or pelts | |
EP0046644B1 (fr) | Procédé de tannage au chrome permettant une meilleure utilisation du chrome | |
US5427594A (en) | Process for pickling raw hides | |
JPS6336360B2 (fr) | ||
DE2113214A1 (de) | Verfahren zum Behandeln geaescherter Bloessen | |
JP3081677B2 (ja) | クロム鞣用有機組成物の製造方法 | |
SU1638165A1 (ru) | Способ выработки кож дл верха обуви из шкур крупного рогатого скота | |
RU2160782C1 (ru) | Способ обработки мехового сырья | |
US4322210A (en) | Auxiliary, and process, for the soaking of hides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN PUBLISHED |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17P | Request for examination filed |
Effective date: 20190502 |
|
RBV | Designated contracting states (corrected) |
Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
17Q | First examination report despatched |
Effective date: 20190605 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTG | Intention to grant announced |
Effective date: 20210420 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 1417059 Country of ref document: AT Kind code of ref document: T Effective date: 20210815 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602018021090 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG9D |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20210804 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 1417059 Country of ref document: AT Kind code of ref document: T Effective date: 20210804 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210804 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210804 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210804 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210804 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210804 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211104 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211206 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210804 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211104 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210804 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210804 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210804 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211105 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210804 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210804 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602018021090 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210804 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210804 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210804 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210804 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210804 Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210804 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20220506 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210804 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210804 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210804 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20220704 |
|
REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20220731 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220704 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220731 Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220731 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220731 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220704 Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220731 |
|
P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230525 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220704 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20230719 Year of fee payment: 6 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20180704 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210804 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210804 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210804 |